These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 33370020)

  • 21. Racial Disparities and Trends in Pancreatic Cancer Incidence and Mortality in the United States.
    Tavakkoli A; Singal AG; Waljee AK; Elmunzer BJ; Pruitt SL; McKey T; Rubenstein JH; Scheiman JM; Murphy CC
    Clin Gastroenterol Hepatol; 2020 Jan; 18(1):171-178.e10. PubMed ID: 31202981
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gastroenteropancreatic neuroendocrine (carcinoid) tumors in children.
    Johnson PR
    Semin Pediatr Surg; 2014 Apr; 23(2):91-5. PubMed ID: 24931354
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Incidence trend of neuroendocrine tumors and disparities by sex and race/ethnicity in adults from the United States, 2000-2020.
    Zhu Y
    Eur J Cancer Prev; 2024 Sep; 33(5):475-484. PubMed ID: 38375858
    [TBL] [Abstract][Full Text] [Related]  

  • 24. It's more than just cancer biology: Health disparities in patients with pancreatic neuroendocrine tumors.
    Underwood PW; Riner AN; Neal D; Cameron ME; Yakovenko A; Reddy S; Rose JB; Hughes SJ; Trevino JG
    J Surg Oncol; 2021 Dec; 124(8):1390-1401. PubMed ID: 34499741
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pancreatic cancer disparities in African Americans.
    Khawja SN; Mohammed S; Silberfein EJ; Musher BL; Fisher WE; Van Buren G
    Pancreas; 2015 May; 44(4):522-7. PubMed ID: 25872128
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Polish diagnostic and therapeutic guidelines in gastroenteropancreatic neuroendocrine tumors (GEP NET)].
    Kos-Kudła B;
    Endokrynol Pol; 2006; 57(3):267-72. PubMed ID: 17111342
    [No Abstract]   [Full Text] [Related]  

  • 27. Survival and clinical outcome of patients with neuroendocrine tumors of the gastroenteropancreatic tract in a german referral center.
    Pape UF; Böhmig M; Berndt U; Tiling N; Wiedenmann B; Plöckinger U
    Ann N Y Acad Sci; 2004 Apr; 1014():222-33. PubMed ID: 15153439
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Persistence of racial disparities in early-stage lung cancer treatment.
    Wolf A; Alpert N; Tran BV; Liu B; Flores R; Taioli E
    J Thorac Cardiovasc Surg; 2019 Apr; 157(4):1670-1679.e4. PubMed ID: 30685165
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Incidence Trends of Gastroenteropancreatic Neuroendocrine Tumors in the United States.
    Lee MR; Harris C; Baeg KJ; Aronson A; Wisnivesky JP; Kim MK
    Clin Gastroenterol Hepatol; 2019 Oct; 17(11):2212-2217.e1. PubMed ID: 30580091
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chromogranin A is a reliable biomarker for gastroenteropancreatic neuroendocrine tumors in an Asian population of patients.
    Chou WC; Hung YS; Hsu JT; Chen JS; Lu CH; Hwang TL; Rau KM; Yeh KY; Chen TC; Sun CF
    Neuroendocrinology; 2012; 95(4):344-50. PubMed ID: 22343505
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinicopathological features and prognosis factors for survival in elderly patients with pancreatic neuroendocrine tumor: A STROBE-compliant article.
    Li G; Tian ML; Bing YT; Tao LY; Wang HY; Jiang B; Yuan CH; Xiu DR
    Medicine (Baltimore); 2019 Mar; 98(11):e14576. PubMed ID: 30882623
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Racial/ethnic disparities in hepatocellular carcinoma treatment and survival in California, 1988-2012.
    Stewart SL; Kwong SL; Bowlus CL; Nguyen TT; Maxwell AE; Bastani R; Chak EW; Chen MS
    World J Gastroenterol; 2016 Oct; 22(38):8584-8595. PubMed ID: 27784971
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuroendocrine gastroenteropancreatic tumours: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
    Oberg K; Akerström G; Rindi G; Jelic S;
    Ann Oncol; 2010 May; 21 Suppl 5():v223-7. PubMed ID: 20555086
    [No Abstract]   [Full Text] [Related]  

  • 34. Impact of Integrated Health Care Delivery on Racial and Ethnic Disparities in Pancreatic Cancer.
    Chang JI; Huang BZ; Wu BU
    Pancreas; 2018 Feb; 47(2):221-226. PubMed ID: 29329156
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Best prognostic factor of neuroendocrine tumors: Grade or Stage? A multidisciplinary single-center study.
    Özaslan E; Bayram F; Karaca H; Gürsoy Ş; Öztürk F; Sözüer E; Abdurrezzak Ü; Yurci A; Can Sezgin G; Yıldırım A; Başpınar O; Kula M; Özkan M
    Turk J Gastroenterol; 2016 Nov; 27(6):509-514. PubMed ID: 27852541
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Trends in diagnosis of gastroenteropancreatic neuroendocrine tumors (GEP-NETs) in India: A report of multicenter data from a web-based registry.
    Palepu J; Shrikhande SV; Bhaduri D; Shah RC; Sirohi B; Chhabra V; Dhar P; Sastry R; Sikora S
    Indian J Gastroenterol; 2017 Nov; 36(6):445-451. PubMed ID: 29457213
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Localized high-grade gastroenteropancreatic neuroendocrine tumors: Defining prognostic and therapeutic factors for a disease of increasing clinical significance.
    Mosquera C; Koutlas NJ; Fitzgerald TL
    Eur J Surg Oncol; 2016 Oct; 42(10):1471-7. PubMed ID: 27528467
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cases in the Management of GEP-NETs: Combination Regimens.
    Braiteh F
    Clin Adv Hematol Oncol; 2016 Apr; 14(4 Suppl 6):11-3. PubMed ID: 27167993
    [No Abstract]   [Full Text] [Related]  

  • 39. Thirteen-month registration of patients with gastroenteropancreatic endocrine tumours in France.
    Lombard-Bohas C; Mitry E; O'Toole D; Louvet C; Pillon D; Cadiot G; Borson-Chazot F; Aparicio T; Ducreux M; Lecomte T; Etienne PL; Cacheux W; Legoux JL; Seitz JF; Ruszniewski P; Chayvialle JA; Rougier P;
    Neuroendocrinology; 2009; 89(2):217-22. PubMed ID: 18719344
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Laboratory, Clinical, and Survival Outcomes Associated With Peptide Receptor Radionuclide Therapy in Patients With Gastroenteropancreatic Neuroendocrine Tumors.
    Kipnis ST; Hung M; Kumar S; Heckert JM; Lee H; Bennett B; Soulen MC; Pryma DA; Mankoff DA; Metz DC; Eads JR; Katona BW
    JAMA Netw Open; 2021 Mar; 4(3):e212274. PubMed ID: 33755166
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.